| 201 |
BRATODX |
ENCORAFENIB 75 MG |
CAPSULE |
BOTTLE |
IN COMBINATION WITH BINIMETINIB FOR THE TREATMENT OF PATIENTS WITH UNRESECTABLE OR METASTATIC MELANOMA WITH A BRAF V600E OR V600K MUTATION |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1201/24 |
24-SEP-2024 |
23-SEP-2029 |
View |
| 202 |
BRIGADX |
BRIGATINIB 180 MG |
FILM COATED TABLET |
BOTTLE |
FOR THE TREATMENT OF ADULT PATIENTS WITH ANAPLASTIC LYMPHOMA KINASE-POSITIVE METASTATIC NON SMALL CELL LUNG CANCER |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
12 L 1270/24 |
25-DEC-2024 |
24-DEC-2029 |
View |
| 203 |
BRIGADX |
BRIGATINIB 90 MG |
FILM COATED TABLET |
BOTTLE |
FOR THE TREATMENT OF ADULT PATIENTS WITH ANAPLASTIC LYMPHOMA KINASE-POSITIVE METASTATIC NON SMALL CELL LUNG CANCER |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
12 L 1271/24 |
25-DEC-2024 |
24-DEC-2029 |
View |
| 204 |
BROFENDX TM |
IBUPROFEN 100 MG |
FILM COATED TABLET |
BOTTLE |
TO RELIEVE PAIN, TENDERNESS, SWELLING, AND STIFFNESS CAUSED BY OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS , ALSO USE TO RELIEVE MILD TO MODERATE PAIN, |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
02 L 1064/24 |
19-FEB-2024 |
18-FEB-2027 |
View |
| 205 |
CABODX 20 MG |
CABOZANTINIB 20 MG |
CAPSULE |
BOTTLE |
TREATMENT OF MEDULLARY THYROID CANCER |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1013/23 |
20-SEP-2023 |
19-SEP-2026 |
View |
| 206 |
CABODX 60 MG |
CABOZANTINIB 60 MG |
CAPSULE |
BOTTLE |
TREATMENT OF MEDULLARY THYROID CANCER |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1011/23 |
20-SEP-2023 |
19-SEP-2026 |
View |
| 207 |
CABODX 80 MG |
CABOZANTINIB 80 MG |
CAPSULE |
BOTTLE |
TREATMENT OF MEDULLARY THYROID CANCER |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1012/23 |
20-SEP-2023 |
19-SEP-2026 |
View |
| 208 |
CAMPMADX |
CAPMATINIB 200 MG |
FILM COATED TABLET |
BOTTLE |
TO TREAT NON SMALL CELL LUNG CANCER THAT SPREAD TO NEARBY TISSUE OR OTHER PARTS OF THE BODY |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
04 L 0962/23 |
28-APR-2023 |
27-APR-2026 |
View |
| 209 |
LANZAAR 50 |
LOSARTAN POTASSIUM 50 MG |
FILM-COATED TABLETS |
ALU-PVDC BLISTERPACK |
TREATMENT OF HYPERTENSION (HTN), DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS( NIDDM) AND A HISTORY OF HYPERTENSION. STROKE RISK REDUCTION IN PATIENTS WITH HTN AND LEFT VENTRICULAR HYPERTROPHY |
NULL |
BERLIN PHARMA LAO CO.,LTD |
BERLIN PHARMACEUTICAL INDUSTRY CO., LTD. |
THAILAND |
STEP 1: RECEIVE (RENEW) |
03 I 3710/12 |
14-SEP-2022 |
13-SEP-2025 |
View |
| 210 |
CAPIVADX |
CAPIVASERTIB 160 MG |
FILM COATED TABLET |
BOTTLE |
IN COMBINATION WITH FULVESTRANT FOR THE TREATMENT OF ADULT PATIENTS WITH HORMONE RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 NEGATIVE, LOCALLY ADVANCED OR MESTASTATIC BREAST CANCER WITH ONE OR MORE PIK2CA/AKT1/PTEN-ALTERATIONS |
NULL |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
12 L 1267/24 |
25-DEC-2024 |
24-DEC-2029 |
View |
